GO:2000479 regulation of cAMP-dependent protein kinase activity: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000479 describes any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase (PKA) activity, a central node in cAMP signal transduction [1, 5].
• PKA regulation can occur through second-messenger binding, subcellular localization, post-translational modification such as glutathionylation, and interaction with regulatory subunits [2, 5, 8].
• Dysregulated PKA activity is linked to impaired calcium signaling, endothelial cytoskeletal rearrangement, defective erythropoiesis, and altered cell cycle progression in thyroid cells [1, 3, 7, 8].
• PKA regulation is conserved across eukaryotes, including roles in calcium tolerance in Schizosaccharomyces pombe and synaptic NMDA receptor modulation in neurons [4, 6].
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of PKA regulatory components in disease-relevant cell types [3, 7, 8].
• EDITGENE provides end-to-end CRISPR cell model generation and library screening to study GO:2000479-related genes at scale.
Description
GO:2000479, regulation of cAMP-dependent protein kinase activity, is a biological process that controls the frequency, rate, or extent of PKA catalytic activity [1, 5]. PKA is a serine/threonine kinase activated by the second messenger cAMP, and its regulation is essential for translating extracellular signals into precise cellular responses [5, 6]. Because PKA phosphorylates a vast array of substrates, its activity must be tightly regulated in time and space to avoid inappropriate signaling [2, 8]. Researchers study GO:2000479 to understand how cells tune cAMP-PKA signaling during processes such as calcium release, cytoskeletal rearrangement, erythropoiesis, and cell cycle progression [1, 3, 7, 8]. The term encompasses diverse regulatory inputs, including second-messenger binding, subcellular localization, redox modification, and interaction with regulatory subunits [2, 5, 8]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:2000479, its mechanisms, associated genes, disease relevance, and experimental approaches.
regulation of cAMP-dependent protein kinase activity At A Glance
| GO ID | GO:2000479 |
|---|---|
| GO term | regulation of cAMP-dependent protein kinase activity |
| Ontology | biological_process |
| Synonym | regulation of PKA; regulation of protein kinase A activity; regulation of cAMP-dependent protein kinase |
| Major function | Modulates the frequency, rate or extent of PKA catalytic activity |
| Related activity | cAMP-dependent protein kinase activity |
| Taxonomic scope | Eukaryotes, including mammals and fungi |
| Representative regulators | cAMP, PRKAR subunits, glutathionylation enzymes, anchoring proteins |
| Disease relevance | Calcium signaling, cytoskeleton, erythropoiesis, cell cycle, neuronal signaling |
What Is GO:2000479?
GO:2000479 is defined by QuickGO as any process that modulates the frequency, rate or extent of cAMP-dependent protein kinase activity. In practical terms, it covers all molecular and cellular events that change how active PKA is in a cell, including activation by cAMP, inhibition by regulatory subunits, localization to specific compartments, and post-translational modifications that alter catalytic output [2, 5, 8].
Why Is regulation of cAMP-dependent protein kinase activity Important in Cell Biology?
GO:2000479 is important because PKA sits at the convergence of many signaling pathways, and its dysregulation contributes to diverse pathologies ranging from defective calcium handling and cytoskeletal disorders to anemia and cancer-related cell cycle defects [1, 3, 7, 8]. Understanding how PKA activity is regulated provides mechanistic insight into signal transduction and identifies candidate therapeutic targets.
• Controls agonist-specific calcium signaling through regulation of Ca2+ release.
• Modulates endothelial cell cytoskeleton rearrangement, affecting barrier and migration functions.
• Regulates erythropoiesis, linking PKA signaling to red blood cell production.
• Influences cell cycle progression in thyroid cells, with implications for proliferation control.
• Mediates beta-adrenergic regulation of synaptic NMDA receptors in neurons.
• Supports calcium tolerance through Prz1 regulation in Schizosaccharomyces pombe.
• Is subject to redox regulation via glutathionylation, connecting PKA to oxidative stress responses.
• Can be activated without dissociation, revealing non-canonical regulatory modes.
• Provides a target for pharmacological and genetic manipulation in disease models [1, 3, 7, 8].
• Serves as a paradigm for studying second-messenger-dependent kinase regulation [5, 6].
What Happens During regulation of cAMP-dependent protein kinase activity?
Second-messenger activation by cAMP
In simple terms: cAMP binds to PKA and turns it on.
The canonical activation of PKA involves binding of cAMP to the regulatory subunits of the PKA holoenzyme, which relieves inhibition of the catalytic subunits. This step is a core component of GO:2000479 because it directly modulates the frequency and extent of PKA catalytic activity. Studies have shown that enzyme activation can occur without full dissociation of regulatory and catalytic subunits, indicating additional layers of regulation.
Subcellular localization and anchoring
In simple terms: Where PKA sits in the cell determines what it can do.
The localization and activity of PKA affect cell cycle progression in thyroid cells, demonstrating that spatial regulation is integral to GO:2000479. Anchoring proteins and compartmentalization restrict PKA activity to specific substrates and microdomains, thereby shaping signaling specificity. This regulatory mechanism ensures that cAMP signals are translated into localized phosphorylation events.
Redox regulation by glutathionylation
In simple terms: Oxidative modification can change PKA activity.
PKA activity is regulated by glutathionylation, a reversible post-translational modification that links redox state to kinase function. This modification can alter catalytic activity and represents a non-canonical regulatory input within GO:2000479. Such redox sensitivity allows PKA signaling to respond to cellular oxidative stress.
Regulation of downstream calcium and synaptic signaling
In simple terms: PKA regulation controls calcium release and nerve cell receptors.
PKA regulates Ca2+ release in an agonist-specific manner, providing a mechanism for differential calcium signaling. In neurons, beta-adrenergic signaling regulates synaptic NMDA receptors through PKA, linking GO:2000479 to synaptic plasticity. These examples illustrate how PKA regulation shapes diverse physiological outputs [1, 6].
Conserved roles in fungal calcium tolerance
In simple terms: Even yeast use PKA regulation to handle calcium stress.
In Schizosaccharomyces pombe, cAMP-dependent protein kinase is involved in calcium tolerance through regulation of Prz1. This conserved function highlights the evolutionary breadth of GO:2000479. It also provides a genetically tractable model for studying PKA regulatory mechanisms.
Key Genes Involved in GO:2000479 regulation of cAMP-dependent protein kinase activity
The following genes and proteins are experimentally implicated in the regulation of cAMP-dependent protein kinase activity (GO:2000479) according to the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKACA | Catalytic subunit of PKA | Target of regulatory inputs; mediates phosphorylation of downstream substrates [5, 8] |
| PRKAR1A | Type I regulatory subunit of PKA | Binds cAMP and inhibits catalytic activity; mutations affect PKA regulation |
| PRKAR2A | Type II regulatory subunit of PKA | Provides localization and cAMP responsiveness [5, 8] |
| PRKAR2B | Type II regulatory subunit of PKA | Contributes to PKA holoenzyme regulation |
| PRKACB | Catalytic subunit isoform of PKA | Alternative catalytic isoform with distinct regulation |
| PRKACG | Catalytic subunit isoform of PKA | Testis-specific isoform; less studied in GO:2000479 |
| AKAPs (e.g., AKAP1, AKAP5) | Anchoring proteins | Localize PKA to specific compartments, affecting activity |
| PRZ1 | Transcription factor regulated by PKA in S. pombe | Links PKA regulation to calcium tolerance |
| GRIN1 | NMDA receptor subunit | Target of PKA regulation in synaptic signaling |
| GRIN2A | NMDA receptor subunit | Modulated by beta-adrenergic/PKA signaling |
| ADRB1 | Beta-adrenergic receptor | Upstream regulator of PKA via cAMP |
| ADRB2 | Beta-adrenergic receptor | Upstream regulator of PKA via cAMP |
| EPOR | Erythropoietin receptor | Upstream of cAMP/PKA-mediated erythropoiesis |
| GATA1 | Erythroid transcription factor | Downstream target in PKA-regulated erythropoiesis |
| TSHR | Thyroid-stimulating hormone receptor | Upstream of cAMP/PKA in thyroid cells |
| GSK3B | Glycogen synthase kinase 3 beta | Interacts with PKA signaling in cell cycle regulation |
| PTK2 (FAK) | Focal adhesion kinase | Cytoskeletal target in endothelial cells |
How Is regulation of cAMP-dependent protein kinase activity Regulated?
GO:2000479 is itself regulated at multiple levels. cAMP availability is controlled by adenylyl cyclases and phosphodiesterases, while PKA activity is further tuned by glutathionylation. Subcellular localization via anchoring proteins restricts PKA activity to specific compartments, as shown in thyroid cells where localization affects cell cycle progression. In neurons, beta-adrenergic input regulates synaptic NMDA receptors through PKA, illustrating neurotransmitter control of this process. In S. pombe, PKA regulation is linked to calcium tolerance through Prz1.
regulation of cAMP-dependent protein kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKACA | Cell cycle progression, thyroid proliferation | Knockout or point-mutation in thyroid cell lines |
| PRKAR1A | Erythropoiesis, hematological disorders | Knock-in of regulatory subunit mutations in erythroid progenitors |
| PRKAR2A | Calcium signaling, endothelial dysfunction | Overexpression in endothelial cells [1, 3] |
| GRIN1/GRIN2A | Synaptic signaling, neurodegeneration | Knockout in neuronal cultures |
| PRZ1 | Calcium tolerance (fungal model) | Knockout in S. pombe |
PKA regulation in calcium signaling disorders
PKA regulation of Ca2+ release provides a mechanism for agonist-specific calcium signaling, and its disruption may contribute to diseases characterized by abnormal calcium handling. Experimental evidence shows that PKA modulates Ca2+ release, linking GO:2000479 to calcium-dependent pathologies.
PKA regulation in endothelial and cytoskeletal disease
PKA activity is required for endothelial cell cytoskeleton rearrangement, a process relevant to vascular permeability and cell migration. Dysregulation of this pathway may contribute to endothelial dysfunction.
PKA regulation in hematological disorders
cAMP/PKA-mediated regulation of erythropoiesis connects GO:2000479 to red blood cell production. Defects in this regulation could contribute to anemias or erythroid disorders.
PKA regulation in cancer and cell cycle control
The localization and activity of PKA affect cell cycle progression in thyroid cells, suggesting a role in proliferative diseases including thyroid cancer. Altered PKA regulation may therefore influence tumor cell cycle dynamics.
From regulation of cAMP-dependent protein kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PRKACA affect cell cycle progression? | PRKACA knockout in thyroid cells |
| Does a point mutation in PRKAR1A alter PKA regulation? | Point-mutation knock-in in erythroid cells |
| Can overexpression of PRKAR2A modulate calcium signaling? | Overexpression in endothelial cells [1, 3] |
| How does PKA regulate synaptic NMDA receptors? | Knockout of GRIN subunits in neurons |
| Is Prz1 required for PKA-mediated calcium tolerance? | Prz1 knockout in S. pombe |
| Does glutathionylation site mutation affect PKA activity? | Point mutation of cysteine residues in PKA subunits |
How to Study the regulation of cAMP-dependent protein kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| PKA kinase assay | Catalytic activity of PKA | Quantifying regulation of PKA activity |
| Calcium imaging | Intracellular Ca2+ release | Agonist-specific calcium signaling |
| Glutathionylation detection | Redox modification of PKA | Studying post-translational regulation |
| Cytoskeleton microscopy | Actin/tubulin rearrangement | Endothelial cell migration |
| Flow cytometry | Cell cycle distribution | Thyroid cell proliferation |
| Electrophysiology | NMDA receptor currents | Synaptic PKA regulation |
| Erythroid differentiation assay | Hemoglobin expression | cAMP/PKA-mediated erythropoiesis |
| Fungal growth assay | Calcium tolerance | S. pombe Prz1 regulation |
Kinase activity assays
PKA activity can be measured using in vitro kinase assays with synthetic substrates, as demonstrated in studies of enzyme activation without dissociation. These assays quantify the frequency and rate of PKA catalytic activity, directly reflecting GO:2000479.
Calcium imaging
Calcium release regulated by PKA can be monitored using fluorescent calcium indicators, as shown in studies of agonist-specific calcium signaling. This method links GO:2000479 to dynamic calcium responses.
Cytoskeleton and migration assays
Endothelial cytoskeleton rearrangement can be assessed by microscopy and migration assays following PKA modulation. These approaches reveal functional consequences of PKA regulation.
Cell cycle analysis
Flow cytometry and proliferation assays can measure cell cycle progression in thyroid cells with altered PKA localization or activity. This connects GO:2000479 to proliferative control.
How CRISPR Can Be Used to Study GO:2000479 regulation of cAMP-dependent protein kinase activity
Knockout
CRISPR knockout of PRKACA, PRKAR1A, or PRKAR2A can abolish specific PKA regulatory components, allowing researchers to test their necessity in processes such as cell cycle progression and erythropoiesis [7, 8]. Knockout of GRIN subunits in neurons can reveal PKA-dependent synaptic regulation.
Point Mutation
Point mutations in PKA subunits, such as cysteine residues subject to glutathionylation, can be introduced to dissect redox regulation of PKA activity. Point mutations in PRKAR1A can model disease-associated variants affecting cAMP binding.
Knock-in
Knock-in of tagged PKA subunits enables localization studies and interaction mapping, which are critical for understanding compartmentalized PKA regulation. Knock-in of disease-relevant mutations can model altered PKA signaling in thyroid or erythroid cells [7, 8].
Overexpression
Overexpression of PKA subunits or anchoring proteins can amplify or mislocalize PKA activity, revealing gain-of-function effects in calcium signaling and cytoskeletal dynamics [1, 3]. Overexpression models are useful for testing whether increased PKA regulation drives pathological phenotypes [1, 3].
How EDITGENE Supports regulation of cAMP-dependent protein kinase activity Research
Researchers studying regulation of cAMP-dependent protein kinase activity-related genes often need to determine whether a candidate gene is causally involved in PKA regulation or downstream signaling. EDITGENE provides validated CRISPR cell models and screening services to accelerate this causal analysis.
Contact EDITGENE today to design your custom CRISPR model for regulation of cAMP-dependent protein kinase activity research.
Frequently Asked Questions About regulation of cAMP-dependent protein kinase activity
What is GO:2000479?
GO:2000479 is the Gene Ontology term for regulation of cAMP-dependent protein kinase activity, defined as any process that modulates the frequency, rate or extent of PKA activity [1, 5].
What genes are involved in regulation of cAMP-dependent protein kinase activity?
Key genes include PRKACA, PRKAR1A, PRKAR2A, PRKAR2B, PRKACB, PRKACG, and anchoring proteins such as AKAPs, as well as upstream receptors like ADRB1 and ADRB2 [5, 6, 8].
How is PKA activity regulated?
PKA activity is regulated by cAMP binding, subcellular localization, glutathionylation, and interaction with regulatory subunits [2, 5, 8].
What diseases are linked to PKA dysregulation?
PKA dysregulation is linked to calcium signaling disorders, endothelial dysfunction, erythropoiesis defects, and cell cycle abnormalities in thyroid cells [1, 3, 7, 8].
Can CRISPR be used to study PKA regulation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect the roles of PKA subunits and regulators [2, 5, 7, 8].
What is the role of glutathionylation in PKA regulation?
Glutathionylation is a reversible post-translational modification that regulates PKA activity, linking redox state to kinase function.
How does PKA regulate calcium signaling?
PKA regulates Ca2+ release in an agonist-specific manner, providing a mechanism for differential calcium signaling.
Is PKA regulation conserved in yeast?
Yes, in Schizosaccharomyces pombe, cAMP-dependent protein kinase is involved in calcium tolerance through regulation of Prz1.
What methods are used to study PKA regulation?
Common methods include PKA kinase assays, calcium imaging, glutathionylation detection, cytoskeleton microscopy, flow cytometry, and electrophysiology [1, 2, 3, 5, 6, 8].
How does PKA affect erythropoiesis?
cAMP/PKA-mediated regulation of erythropoiesis controls red blood cell production, and its disruption may contribute to hematological disorders.
Conclusion
GO:2000479, regulation of cAMP-dependent protein kinase activity, is a fundamental biological process that integrates second-messenger signaling, subcellular localization, and post-translational modifications to control PKA output [1, 2, 5, 8]. Its dysregulation is implicated in diverse pathologies, from calcium signaling defects to erythropoiesis and cell cycle disorders [1, 3, 7, 8]. CRISPR-based cell models and screening approaches provide powerful tools to dissect the causal roles of PKA regulatory components, and EDITGENE offers comprehensive services to support such research.
References
- 1. Bugrim AE. 1999. Regulation of Ca2+ release by cAMP-dependent protein kinase. A mechanism for agonist-specific calcium signaling?. Cell Calcium 25(3):219-26 PMID: 10378083
- 2. Humphries KM et al.. 2002. Regulation of cAMP-dependent protein kinase activity by glutathionylation.. J Biol Chem 277(45):43505-11 PMID: 12189155
- 3. Liu F et al.. 2001. Role of cAMP-dependent protein kinase A activity in endothelial cell cytoskeleton rearrangement.. Am J Physiol Lung Cell Mol Physiol 280(6):L1309-17 PMID: 11350812
- 4. Matsuo Y et al.. 2017. cAMP-dependent protein kinase involves calcium tolerance through the regulation of Prz1 in Schizosaccharomyces pombe.. Biosci Biotechnol Biochem 81(2):231-241 PMID: 27756188
- 5. Yang S et al.. 1995. Regulation of cAMP-dependent protein kinase: enzyme activation without dissociation.. Biochemistry 34(19):6267-71 PMID: 7756252
- 6. Raman IM et al.. 1996. Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase.. Neuron 16(2):415-21 PMID: 8789956
- 7. Boer AK et al.. 2003. cAMP/PKA-mediated regulation of erythropoiesis.. Leuk Lymphoma 44(11):1893-901 PMID: 14738140
- 8. Feliciello A et al.. 2000. The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells.. J Biol Chem 275(1):303-11 PMID: 10617619
